Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/37153
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Şimşek, Fikri | - |
dc.contributor.author | Comak, A. | - |
dc.contributor.author | Asik, M. | - |
dc.contributor.author | Kuslu, D. | - |
dc.contributor.author | Balci, T. | - |
dc.contributor.author | Ulutas, H. | - |
dc.contributor.author | Koroglu, R. | - |
dc.date.accessioned | 2021-02-02T09:24:15Z | - |
dc.date.available | 2021-02-02T09:24:15Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 1119-3077 | - |
dc.identifier.uri | https://hdl.handle.net/11499/37153 | - |
dc.identifier.uri | https://doi.org/10.4103/njcp.njcp_2_19 | - |
dc.description.abstract | Background: The most widely accepted approach nowadays in nodal staging of non-small cell lung cancer (NSCLC) is the combined use of 18-Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) and endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA). However, this approach may not be sufficient, especially for early stages. Aims: Our aim was to assess whether more satisfactory results can be obtained with standardized uptake value maximum lymph node/standardized uptake value mean mediastinal blood pool (SUVmax LN/SUVmean MBP), SUVmax LN/Primary tumor, or a novel cut-off value to SUVmax in this special group. Subjects and Methods: Patients with diagnosed NSCLC and underwent FDG-PET/CT were reviewed retrospectively. 168 LNs of 52 early stage NSCLC patients were evaluated. The LNs identified in surgery/pathology reports were found in the FDG-PET/CT images. Anatomic and metabolic parameters were measured. Statistical analysis was performed by using of MedCalc Statistical Software. Results: Regardless of LNs size; sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of SUVmax >2.5 were 91.5%, 65.9%, 58.2%, and 95.1%, respectively. Optimum cut-off value of SUVmax was >4.0. Sensitivity, specificity, PPV, and NPV were found as 81.0%, 90.0%, 81.0%, and 90.0% respectively. Optimum cut-off value of SUVmax LN/SUVmean MBP was >1.71. Sensitivity, specificity, PPV, and NPV were found as 94.7%, 80.0%, 71.1%, and 96.7%, respectively. Optimum cut-off value of SUVmax LN/Primary tumor was >0.28. Sensitivity, specificity, PPV, and NPV were found as 81.1%, 85.1%, 72.9% and 90.1%, respectively. Conclusion: SUVmax LN/SUVmean MBP >1.71 has higher PPV than currently used, with similar NPV and sensitivity. This can provide increase in the accuracy of combined approach. In this way, faster nodal staging/treatment decisions, cost savings for healthcare system and time saving of medical professionals can be obtained. © 2020 Nigerian Journal of Clinical Practice - Published by Wolters Kluwer - Medknow. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.ispartof | Nigerian Journal of Clinical Practice | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | EBUS-TBNA | en_US |
dc.subject | FDG-PET/CT | en_US |
dc.subject | NSCLC | en_US |
dc.subject | staging | en_US |
dc.subject | fluorodeoxyglucose f 18 | en_US |
dc.subject | radiopharmaceutical agent | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | cancer staging | en_US |
dc.subject | diagnostic imaging | en_US |
dc.subject | endoscopic ultrasonography | en_US |
dc.subject | female | en_US |
dc.subject | fine needle aspiration biopsy | en_US |
dc.subject | human | en_US |
dc.subject | lung tumor | en_US |
dc.subject | lymph node | en_US |
dc.subject | lymph node metastasis | en_US |
dc.subject | male | en_US |
dc.subject | mediastinum | en_US |
dc.subject | metabolism | en_US |
dc.subject | middle aged | en_US |
dc.subject | multimodal imaging | en_US |
dc.subject | non small cell lung cancer | en_US |
dc.subject | pathology | en_US |
dc.title | Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients? | en_US |
dc.type | Other | en_US |
dc.identifier.volume | 23 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 842 | - |
dc.identifier.startpage | 842 | en_US |
dc.identifier.endpage | 847 | en_US |
dc.identifier.doi | 10.4103/njcp.njcp_2_19 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.pmid | 32525121 | en_US |
dc.identifier.scopus | 2-s2.0-85086355404 | en_US |
dc.identifier.wos | WOS:000543398100016 | en_US |
dc.identifier.scopusquality | Q3 | - |
dc.owner | Pamukkale University | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairetype | Other | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
1
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
1
checked on Oct 31, 2024
Page view(s)
30
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.